SCHEMBL4537613

SCHEMBL4537613

O=C(NCc1cnc(Oc2ccc(F)cc2)nc1)c1cccn1-c1ncc(Cl)cc1Cl

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.48
PPARG P37231 1/20 0.48
KMT2A Q03164 1/20 0.48
NR2E3 Q9Y5X4 1/20 0.48
NCOR2 Q9Y618 1/20 0.48
PTGER4 P35408 4/20 0.46
PTGER2 P43116 1/20 0.46
CYP3A4 P08684 2/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
CNR2 P34972 1/20 0.41
MAPT P10636 2/20 0.40
NPSR1 Q6W5P4 1/20 0.40
MAPK14 Q16539 1/20 0.37
LIPG Q9Y5X9 1/20 0.36
DGAT2 Q96PD7 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4542797 0.92 PTGER4 (0.52) MEN1PPARGKMT2ANR2E3NCOR2
SCHEMBL4542354 0.91 MEN1 (0.56) MEN1PPARGKMT2ANR2E3NCOR2
SCHEMBL4543653 0.90 MEN1 (0.47) MEN1PPARGKMT2ANR2E3NCOR2
SCHEMBL4544019 0.88 PPARG (0.52) MEN1PPARGKMT2ANR2E3NCOR2
SCHEMBL4541439 0.88 MEN1 (0.47) MEN1PPARGKMT2ANR2E3NCOR2
SCHEMBL4540706 0.87 MEN1 (0.59) MEN1PPARGKMT2ANR2E3NCOR2
SCHEMBL4542997 0.86 MEN1 (0.49) MEN1PPARGKMT2ANR2E3NCOR2
SCHEMBL4539824 0.86 MEN1 (0.47) MEN1PPARGKMT2ANR2E3NCOR2
SCHEMBL4541900 0.86 MEN1 (0.47) MEN1PPARGKMT2ANR2E3NCOR2
SCHEMBL4543824 0.86 MEN1 (0.48) MEN1PPARGKMT2ANR2E3NCOR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009117421-A2 HETEROCYCLIC MODULATORS OF GPR119 FOR TREATMENT OF DISEASE KALYPSYS, INC. (US) 2009-09-24 WO disclosed
WO-2009117421-A2 HETEROCYCLIC MODULATORS OF GPR119 FOR TREATMENT OF DISEASE KALYPSYS, INC. (US) 2009-09-24 WO disclosed